We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gamida Cell Snags Full Approval for Stem Cell Product that Reduces Risk of Infection
Gamida Cell Snags Full Approval for Stem Cell Product that Reduces Risk of Infection
The FDA has approved Omisirge (omidubicel-onlv), Gamida Cell’s first-in-class allogeneic umbilical cord-blood stem cell treatment for blood cancers, which carries a unique twist that increases their immune-boosting potential.